Table 3.
List of fields in DrugBank targeted by our tool.
| Field Name | Description | Example |
|---|---|---|
| DrugBank ID | Unique reference with prefix “DB” | DB00317 |
| Molecule Type | Either “small molecule” or “biotech” | Small molecule |
| Description | General facts, composition and/or preparation of the drug molecule | |
| Name | Standard name of drug provided by the manufacturer | Gefitinib |
| Brand Names | Brand names from different manufacturers. Names are separated by a semicolon | Iressa;Tarceva |
| Prices | Unit cost drug prices in USD. Prices are separated by a semicolon | Tarceva 25 mg tablet USD 52.78; Iressa 250 mg tablet USD 68.08 |
| Synonyms | List of alternate names separated by a semicolon | Iressa; gefitinib; ZD 1839 |
| Pharmacology Indication | Identify neoplasm-specific MeSH terms. | Metastatic non-small lung cancer |
| Target Genes | Names of the gene targeted by the drug. Names are separated by a semicolon | EGFR |
| SNP Effects SNP Adverse |
Known single nucleotide polymorphisms that may affect the potency of the drug. Multiple SNP effects are separated by a semicolon. A dash is shown if there is no known SNP effect. | G719A/C or ... ABCG2 ATP-binding ... |
SNP: single nucleotide polymorphism.